Michael Roth, M.D.

University of California, Los Angeles
email: mroth@mednet.ucla.edu

Grants

A New Approach to Immune Therapy for Breast Cancer 1996 (Cycle II)
ITaMoCAs 2CB-0160 $204,839


Interferon-alpha and granulocyte-macrophage colony-stimulating factor differentiate peripheral bloodmonocytes into potent antigen-presenting cells
  Periodical: Journal of Leukocyte Biology
  Author(s): Paquette RL, Hsu NC, Kiertscher SM, Park AN, Tran L, Roth MD, and Glaspy J
  Yr: 1998 Vol: 64 Nbr: 3 Pgs: 358-367
  Associated Grant: A New Approach to Immune Therapy for Breast Cancer
 
Costimulation of naive CD8(+) lymphocytes induces CD4 expression and allows human immunodeficiency virus type 1 infection
  Periodical: Journal of Virology
  Author(s): Kitchen SG, Korin YD, Roth MD, Landay A, and Zack JA
  Yr: 1998 Vol: 72 Nbr: 11 Pgs: 9054-9060
  Associated Grant: A New Approach to Immune Therapy for Breast Cancer